Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome – a prospective randomized double-blind clinical trial

被引：0
|
作者：
L. L. Engmann
B. S. Maslow
L. A. Kaye
D. W. Griffin
A. J. DiLuigi
D. W. Schmidt
D. R. Grow
J. C. Nulsen
C. A. Benadiva
机构：
[1] Center for Advanced Reproductive Services,Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology
[2] University of Connecticut School of Medicine,undefined
[3] Gold Coast IVF,undefined
[4] Boston IVF at the Women’s Hospital,undefined
[5] Center for Advanced Reproductive Services,undefined
来源：
Journal of Ovarian Research | / 12卷
关键词：
Dual trigger; Leuprolide trigger; Gonadotropin-releasing hormone agonist; Ovarian hyperstimulation syndrome; OHSS; Low dose human chorionic gonadotropin; hCG and agonist trigger; Luteal support;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 12 条
  • [1] Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial
    Engmann, L. L.
    Maslow, B. S.
    Kaye, L. A.
    Griffin, D. W.
    DiLuigi, A. J.
    Schmidt, D. W.
    Grow, D. R.
    Nulsen, J. C.
    Benadiva, C. A.
    JOURNAL OF OVARIAN RESEARCH, 2019, 12
  • [2] Gonadotropin releasing hormone (GnRH) antagonist administration to decrease the risk of ovarian hyperstimulation syndrome in GNRH agonist cycles triggered with human chorionic gonadotropin
    Ginevra Mills
    Michael H. Dahan
    Archives of Gynecology and Obstetrics, 2022, 306 : 1731 - 1737
  • [3] Gonadotropin releasing hormone (GnRH) antagonist administration to decrease the risk of ovarian hyperstimulation syndrome in GNRH agonist cycles triggered with human chorionic gonadotropin
    Mills, Ginevra
    Dahan, Michael H.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 306 (05) : 1731 - 1737
  • [4] Triggering ovulation with gonadotropin-releasing hormone agonist versus human chorionic gonadotropin in polycystic ovarian syndrome. A randomized trial
    Farag, Amr Hassaan
    El-deen, Mohamed Hassan Nasr
    Hassan, Rasha Mostafa
    MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2015, 20 (04) : 217 - 223
  • [5] DOUBLE DUTY?: IMPACT OF A DELAYED DOSE OF GONADOTROPIN-RELEASING HORMONE AGONIST (GNRH-A) AFTER A DUAL TRIGGER ON OOCYTES RETRIEVED AND RISK OF OVARIAN HYPERSTIMULATION SYNDROME (OHSS).
    Blakemore, J. K.
    McCulloh, D. H.
    Grifo, J. A.
    FERTILITY AND STERILITY, 2018, 110 (04) : E313 - E314
  • [6] Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study
    Bodri, Daniel
    Jose Guillen, Juan
    Trullenque, Marta
    Schwenn, Katja
    Esteve, Carolina
    Coll, Oriol
    FERTILITY AND STERILITY, 2010, 93 (07) : 2418 - 2420
  • [7] PROSPECTIVE DOUBLE-BLIND RANDOMIZED PLACEBO CONTROLLED CLINICAL TRIAL COMPARING PREGNANCY RATES AFTER CO-ADMINISTRATION OF LOW DOSE HCG AT THE TIME OF GNRH-AGONIST TRIGGER OR 35 HOURS LATER, FOR THE PREVENTION OF OHSS.
    Maslow, B. L.
    Griffin, D.
    Benadiva, C. A.
    Nulsen, J.
    Engmann, L.
    FERTILITY AND STERILITY, 2016, 106 (03) : E58 - E58
  • [8] Prevention of ovarian hyperstimulation syndrome (OHSS) with the use of gonadotropin releasing hormone (GnRH) agonist to trigger final oocyte maturation after cotreatment with GnRH antagonist in patients with polycystic ovarian syndrome (PCOS) or previous high response undergoing IVF treatment - A prospective randomized clinical trial.
    Engmann, L
    Diluigi, A
    Schmidt, D
    Nulsen, J
    Maier, D
    Benadiva, C
    FERTILITY AND STERILITY, 2005, 84 : S96 - S96
  • [9] The use of gonadotropin releasing hormone (GnRH) agonist to induce oocyte maturation in high-risk patients undergoing IVF reduces the risk of ovarian hyperstimulation syndrome (OHSS) - A prospective randomized controlled study.
    Engmann, L.
    Diluigi, A.
    Schmidt, D.
    Nulsen, J.
    Maier, D.
    Benadiva, C.
    FERTILITY AND STERILITY, 2006, 86 : S118 - S118
  • [10] Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization cycles: a randomized, double-blind, placebo-controlled trial
    Lamb, Julie D.
    Shen, Shehua
    McCulloch, Charles
    Jalalian, Liza
    Cedars, Marcelle I.
    Rosen, Mitchell P.
    FERTILITY AND STERILITY, 2011, 95 (05) : 1655 - 1660
12